Lohman Technologies’ latest HomECG+ device promotes health equity with ease of use and embedded cellular technology
The latest version of the HomECG+ helps close the health equity gap by enabling access to care for all patient types, including rural health, underserved populations, geographical disparities and low-income populations.
MILWAUKEE, March 2, 2023 /PRNewswire/ — Lohman Technologies recently announced the release of its next-generation HomECG+ product 2.0. The FDA-cleared, clinical remote monitoring solution for detecting atrial fibrillation (AFib) attracts both patients and providers due to its integration capabilities, ease of use and direct connect capability. The embedded cellular capability allows patients to bypass complicated apps and expensive smartphones by sending ECG data directly to their provider, who then logs directly into the provider’s existing RPM (Remote Patient Monitoring) or EMR (Electronic Medical Record) platforms integrated.
“Health equity is a core value of our overall mission,” says Jason Dvorak, President of Lohman Technologies. “This solution fills a gap for patients in remote and rural settings and for patients who may not have a smartphone, which necessitates the complexity of using apps to communicate with their provider. HomECG+ removes all of this from the equation by delivering a patient’s ECG data directly to their doctor.”
The HomECG+ solution is attractive to large healthcare systems serving a wide patient population in need of remote cardiac monitoring. “As a wearable device, we can use the HomECG+ solution as a precursor to a wearable or potential intervention,” says Dr. Robert L Baker (FACC) from Nevada Cardiology Associates. “All the patient has to do is place their thumbs on the sensor pads, take a reading in under a minute, and their doctor can take it from there.”
About Lohman Technologies:
Lohman Technologies is the developer of the HomECG+ solution, an FDA-cleared clinical remote monitoring solution for the detection of atrial fibrillation (AFib). Lohman Technologies’ mission is to continuously improve and impact the continuum of care through innovative remote cardiac monitoring, collaborative partnerships and advancing equity in healthcare. The patented mobile solution HomECG+ connects patient data directly to their healthcare providers without the need for a smartphone or WIFI technology. For more information on how Lohman Technologies connects patients, providers and peace of mind, visit www.homecg.com.
View original content: https://www.prnewswire.com/news-releases/lohman-technologies-latest-homecg-device-promotes-health-equity-with-ease-of-use-and-embedded-cellular-technology-301761246 .html
SOURCE Lohman Technologies